Causes of patient ineligibility in clinical trials of metastatic urothelial cancer.

4556Background: Registrational trials of PD-1/PD-L1 inhibitor therapy help inform clinicians and patients about the expected outcomes of patients receiving these drugs. However, the clinical trial ...